Cite
Decreased Fatty Acid Transporter FABP1 and Increased Isoprostanes and Neuroprostanes in the Human Term Placenta: Implications for Inflammation and Birth Weight in Maternal Pre-Gestational Obesity
MLA
Livia Belcastro, et al. “Decreased Fatty Acid Transporter FABP1 and Increased Isoprostanes and Neuroprostanes in the Human Term Placenta: Implications for Inflammation and Birth Weight in Maternal Pre-Gestational Obesity.” Nutrients, vol. 13, no. 8, Aug. 2021, p. 2768. EBSCOhost, https://doi.org/10.3390/nu13082768.
APA
Livia Belcastro, Carolina S. Ferreira, Marcelle A. Saraiva, Daniela B. Mucci, Antonio Murgia, Carla Lai, Claire Vigor, Camille Oger, Jean-Marie Galano, Gabriela D. A. Pinto, Julian L. Griffin, Alexandre G. Torres, Thierry Durand, Graham J. Burton, Fátima L. C. Sardinha, & Tatiana El-Bacha. (2021). Decreased Fatty Acid Transporter FABP1 and Increased Isoprostanes and Neuroprostanes in the Human Term Placenta: Implications for Inflammation and Birth Weight in Maternal Pre-Gestational Obesity. Nutrients, 13(8), 2768. https://doi.org/10.3390/nu13082768
Chicago
Livia Belcastro, Carolina S. Ferreira, Marcelle A. Saraiva, Daniela B. Mucci, Antonio Murgia, Carla Lai, Claire Vigor, et al. 2021. “Decreased Fatty Acid Transporter FABP1 and Increased Isoprostanes and Neuroprostanes in the Human Term Placenta: Implications for Inflammation and Birth Weight in Maternal Pre-Gestational Obesity.” Nutrients 13 (8): 2768. doi:10.3390/nu13082768.